Pseudomembranous colitis is associated with which of the following medications?
A lady presented with creamy white vaginal discharge with fishy odor. What is the drug of choice?
Which one of the following drugs inhibits bacterial protein synthesis by preventing the translocation step through its interaction with the 50S ribosomal subunit?
Discoloration of the teeth is seen with the intake of which of the following?
What is the fastest acting schizontocidal drug among the following?
Which drug is safe in G6PD deficiency?
Which of the following antifungal drugs is developing drug resistance and has not been prescribed for tinea cruris and tinea corporis for the last 2 years?
All of the following drugs are CYP3A inhibitors except?
What is the drug of choice for the treatment of Tularemia?
A patient is experiencing difficulty in distinguishing red-green lights. Which of the following drugs is most likely responsible for this side effect?
Explanation: **Explanation:** **Pseudomembranous colitis (PMC)** is caused by the overgrowth of *Clostridioides difficile* (formerly *Clostridium*), which produces toxins (Toxin A and B) that damage the colonic mucosa. This occurs when the normal gut flora is suppressed by broad-spectrum antibiotics. **Why Clindamycin is the Correct Answer:** While almost any antibiotic can trigger PMC, **Clindamycin** is the classic agent most strongly associated with it in medical literature and exams. It significantly disrupts the anaerobic balance of the colon, creating an ideal environment for *C. difficile* to proliferate. **Analysis of Incorrect Options:** * **Vancomycin (Option A):** Oral Vancomycin is actually a **treatment** of choice for PMC, not a common cause. It is not absorbed systemically and acts locally in the gut to kill *C. difficile*. * **Lincomycin (Option B):** Although in the same class (Lincosamides) as Clindamycin, it is less commonly used in modern clinical practice and is not the "textbook" answer for this association. * **Rovamycin (Option C):** This is Spiramycin (a macrolide), primarily used for Toxoplasmosis. It is not a major culprit for PMC. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Cause:** While Clindamycin is the "classic" answer, in terms of absolute frequency, **Amoxicillin** and **Cephalosporins** (3rd generation) cause more cases due to their higher volume of use. * **Diagnosis:** Gold standard is the detection of *C. difficile* toxins in stool or visualization of "pseudomembranes" on sigmoidoscopy. * **Treatment:** First-line treatment is **Oral Vancomycin** or **Fidaxomicin**. Metronidazole is now reserved for non-severe cases if other options are unavailable. * **Drug of Choice for MRSA:** Clindamycin is often used for CA-MRSA, but always monitor the patient for diarrhea.
Explanation: ### Explanation The clinical presentation of **creamy white vaginal discharge with a fishy odor** is characteristic of **Bacterial Vaginosis (BV)**. This condition is caused by a shift in vaginal flora, where normal *Lactobacillus* species are replaced by anaerobes, most notably ***Gardnerella vaginalis***, *Prevotella*, and *Mobiluncus*. **Why Metronidazole is the Correct Choice:** Metronidazole is the **Drug of Choice (DOC)** for Bacterial Vaginosis. It is a nitroimidazole that acts by inhibiting DNA synthesis in anaerobic bacteria [1]. According to CDC and standard treatment guidelines, the regimen is typically **500 mg orally twice daily for 7 days**. It effectively targets the overgrowth of anaerobes while sparing the beneficial *Lactobacilli*. **Analysis of Incorrect Options:** * **Doxycycline:** This is the drug of choice for *Chlamydia trachomatis* (often presenting as mucopurulent cervicitis) and Lymphogranuloma Venereum (LGV), but it is ineffective against the anaerobes causing BV. * **Ofloxacin:** A fluoroquinolone used for Pelvic Inflammatory Disease (PID) or urinary tract infections; it does not provide adequate anaerobic coverage for BV. * **Clindamycin:** While Clindamycin is an **alternative** treatment for BV [2] (especially in patients allergic to Metronidazole), it is not the primary drug of choice in standard clinical scenarios. **High-Yield Clinical Pearls for NEET-PG:** * **Amsel’s Criteria for BV:** (Requires 3 out of 4) 1. Thin, homogenous discharge; 2. Vaginal pH > 4.5; 3. **Positive Whiff Test** (fishy odor on adding 10% KOH); 4. Presence of **Clue Cells** on microscopy (most specific). * **Whiff Test:** The fishy odor is due to the release of volatile amines (putrescine/cadaverine). * **Counseling:** Patients on Metronidazole must avoid alcohol due to the **Disulfiram-like reaction** [1]. * **Pregnancy:** Metronidazole is safe to use in pregnant women with symptomatic BV.
Explanation: ### Explanation **Correct Option: A. Clindamycin** Clindamycin is a Lincosamide antibiotic that binds to the **50S ribosomal subunit**. Its primary mechanism of action is the inhibition of the **translocation** step (where the peptidyl-tRNA moves from the A-site to the P-site). By blocking this movement, it prevents the elongation of the peptide chain, thereby inhibiting bacterial protein synthesis. **Analysis of Incorrect Options:** * **B. Gentamicin:** This is an Aminoglycoside. It binds to the **30S subunit**, causing mRNA misreading and inhibition of the initiation complex. It does not target the 50S subunit. * **C. Chloramphenicol:** While it binds to the 50S subunit, its specific mechanism is the inhibition of **peptidyl transferase** (the enzyme that forms peptide bonds), not the translocation step. * **D. Imipenem:** This is a Carbapenem (Beta-lactam). It inhibits **cell wall synthesis** by binding to Penicillin-Binding Proteins (PBPs), not protein synthesis. **High-Yield NEET-PG Pearls:** * **Mnemonic for 50S Inhibitors:** **"CCEL"** – **C**hloramphenicol, **C**lindamycin, **E**rythromycin (Macrolides), and **L**inezolid. * **Translocation Inhibitors:** Both Macrolides (e.g., Azithromycin) and Lincosamides (Clindamycin) inhibit translocation. * **Clinical Association:** Clindamycin is the drug of choice for anaerobic infections above the diaphragm but is notoriously associated with **Pseudomembranous colitis** caused by *Clostridioides difficile*. * **Antagonism:** Clindamycin and Macrolides should not be used together as they have overlapping binding sites on the 50S subunit, leading to antagonistic effects.
Explanation: **Explanation:** The correct answer is **Tetracyclines (Option A)**. **Mechanism of Tooth Discoloration:** Tetracyclines are known for their high affinity for calcium. When administered during the period of tooth development (calcification), they form a **tetracycline-calcium orthophosphate complex**. This complex is deposited in the teeth and bones. Upon exposure to light, this complex undergoes photochemical oxidation, changing from a light yellow to a permanent **brownish-grey discoloration**. This effect occurs during enamel formation, specifically from the **second trimester of pregnancy up to 8 years of age**. Therefore, tetracyclines are generally contraindicated in pregnant women and children. **Analysis of Other Options:** * **Chloramphenicol (Option B):** Primarily associated with "Gray Baby Syndrome" (due to deficient glucuronidation) and bone marrow suppression (aplastic anemia), but it does not cause tooth discoloration. * **Minocycline (Option C) & Lymecycline (Option D):** While these are members of the tetracycline class, the question asks for the general class ("Tetracyclines") as the most appropriate answer. In a NEET-PG context, when a general class is listed alongside specific drugs, the class is preferred unless a specific unique side effect is being highlighted. *Note: Minocycline can cause skin and mucosal pigmentation in adults, but the classic "discoloration of teeth" during development is the hallmark of the class.* **High-Yield Clinical Pearls for NEET-PG:** * **Contraindications:** Tetracyclines are **Category D** in pregnancy. * **Fanconi Syndrome:** Caused by the use of **outdated (expired) tetracyclines** due to degradation products like epianhydrotetracycline. * **Phototoxicity:** Most common with Demeclocycline and Doxycycline. * **Drug of Choice:** Doxycycline is the DOC for Rickettsial infections, Chlamydia, and Cholera. It is unique because it is excreted primarily via bile and is safe in renal failure.
Explanation: **Explanation:** **Artemether** (an Artemisinin derivative) is the correct answer because Artemisinins are the **fastest-acting** antimalarial drugs currently available. They act by releasing free radicals upon reacting with the heme iron in the parasite's food vacuole, leading to rapid destruction of the parasite. Their primary clinical advantage is the ability to achieve a **3-log (1000-fold) reduction** in parasite biomass within two asexual cycles (48 hours), which is significantly faster than any other class. **Analysis of Incorrect Options:** * **Chloroquine:** While it is a potent and rapidly acting blood schizontocide, its rate of parasite clearance is slower than that of Artemisinins. Furthermore, widespread resistance has limited its efficacy. * **Mefloquine:** This is a slow-acting blood schizontocide with a long half-life. It is primarily used for prophylaxis or as part of combination therapy, but it does not provide the rapid initial kill required in severe cases. * **Proguanil:** This is a slow-acting drug that primarily acts as a dihydrofolate reductase inhibitor. It is mainly used for prophylaxis and has limited efficacy as a standalone blood schizontocide. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** For severe/complicated *P. falciparum* malaria, **IV Artesunate** is the drug of choice due to its rapid action. * **ACT:** Artemisinin-based Combination Therapy (e.g., Artemether + Lumefantrine) is the standard for uncomplicated malaria to prevent resistance and ensure complete clearance. * **Short Half-life:** Artemisinins have a very short half-life (~1-2 hours), which is why they must be combined with a long-acting drug (like Lumefantrine or Mefloquine) to prevent recrudescence.
Explanation: **Explanation:** The core concept in G6PD deficiency is the inability of red blood cells to maintain adequate levels of **reduced glutathione**. This makes RBCs vulnerable to oxidative stress caused by certain drugs, leading to hemoglobin denaturation (Heinz bodies) and acute hemolysis. **Why Quinidine is the Correct Answer:** While **Quinine** is known to cause hemolysis in G6PD-deficient individuals, its optical isomer **Quinidine** is generally considered safe at therapeutic doses. In clinical practice and standard pharmacological classifications (such as those by the G6PD Deficiency Association), Quinidine is not listed as a high-risk oxidative trigger, unlike its counterpart Quinine or other antimalarials. **Analysis of Incorrect Options:** * **Primaquine (Option A):** This is the classic "high-yield" trigger. It is an 8-aminoquinoline that causes significant oxidative stress and is strictly contraindicated in G6PD deficiency. * **Acetanilide (Option B):** An older analgesic/antipyretic known to be a potent oxidant. It is a well-documented cause of hemolysis in these patients. * **Dapsone (Option D):** A sulfone used in leprosy and *Pneumocystis* prophylaxis. It is a notorious oxidant drug that causes dose-related hemolysis even in normal individuals, but is catastrophic in G6PD deficiency. **NEET-PG High-Yield Pearls:** * **Mnemonic for G6PD Triggers:** "**S**ell **A**ll **F**ava **B**eans" (**S**ulfonamides/Sulfones, **A**ntimalarials like Primaquine, **F**ava beans, **B**enzocaine/Nitrofurantoin). * **Diagnosis:** Look for "Bite cells" (degmacytes) and "Heinz bodies" on a peripheral smear. * **Inheritance:** It is an X-linked recessive disorder, providing protection against *Falciparum* malaria. * **Chloroquine vs. Primaquine:** Chloroquine is generally safe in G6PD deficiency, whereas Primaquine is not.
Explanation: **Explanation** The correct answer is **Griseofulvin**. **1. Why Griseofulvin is the correct answer:** Griseofulvin was historically the "gold standard" oral treatment for dermatophytosis (Tinea infections). However, in the last few years, particularly in the Indian subcontinent, there has been a significant rise in clinical non-responsiveness and drug resistance. Due to its **fungistatic** nature, long treatment duration (6–12 weeks), and high failure rates compared to newer fungicidal agents, it is no longer recommended as a first-line treatment for Tinea cruris and Tinea corporis in current clinical practice guidelines. **2. Analysis of Incorrect Options:** * **Terbinafine:** An allylamine that inhibits squalene epoxidase. While resistance is emerging, it remains a commonly prescribed first-line systemic agent. * **Itraconazole:** An azole that inhibits 14-α demethylase. It is currently the most frequently prescribed oral antifungal for recalcitrant dermatophytosis due to its high efficacy, despite concerns regarding its pharmacokinetic variability. * **Voriconazole:** A second-generation triazole primarily reserved for invasive aspergillosis and serious systemic fungal infections. It is not indicated or used for routine superficial infections like Tinea cruris. **3. Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Griseofulvin binds to **tubulin**, interfering with microtubule function and inhibiting mitosis (Metaphase arrest). * **Pharmacokinetics:** It is highly insoluble; absorption is significantly increased when taken with a **fatty meal**. * **Indication:** It remains a first-line drug for **Tinea capitis** (especially caused by *Microsporum* species) in the pediatric population. * **Key Side Effect:** It is a potent **CYP450 inducer** and can precipitate attacks of Acute Intermittent Porphyria.
Explanation: ### Explanation The cytochrome P450 (CYP) system, particularly the **CYP3A4** isoenzyme, is responsible for the metabolism of over 50% of clinically used drugs. Understanding its inhibitors and inducers is a high-yield topic for NEET-PG. **Why Saquinavir is the correct answer:** While Saquinavir is a Protease Inhibitor (PI) used in HIV treatment, it is unique among its class because it is a **substrate** of CYP3A4 but **not a potent inhibitor**. In clinical practice, Saquinavir has poor bioavailability on its own. To counteract this, it is often "boosted" with **Ritonavir**, which inhibits the CYP3A4 enzymes that would otherwise rapidly break Saquinavir down. **Analysis of Incorrect Options:** * **Erythromycin:** A classic Macrolide antibiotic known to be a potent inhibitor of CYP3A4. It frequently causes drug interactions with theophylline, warfarin, and statins. (Note: Azithromycin is the exception among macrolides as it does not inhibit CYP enzymes). * **Itraconazole:** Azole antifungals are notorious CYP3A4 inhibitors. Itraconazole and Ketoconazole are among the most potent inhibitors in this class. * **Ritonavir:** This is the **most potent CYP3A4 inhibitor** known. In HAART therapy, it is used in low doses specifically for its enzyme-inhibiting property to increase the plasma concentration of other protease inhibitors (Pharmacokinetic boosting). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for CYP Inhibitors (SICKFACES.COM):** **S**odium Valproate, **I**soniazid, **C**imetidine, **K**etoconazole, **F**luconazole, **A**lcohol (acute), **C**hloramphenicol, **E**rythromycin, **S**ulfonamides, **C**iprofloxacin, **O**meprazole, **M**etronidazole/Grapefruit juice. * **Protease Inhibitors:** Most PIs inhibit CYP3A4 (Ritonavir > Indinavir > Nelfinavir), but **Saquinavir** is the notable exception with negligible inhibitory effect. * **Clinical Consequence:** Inhibition leads to decreased metabolism of co-administered drugs, resulting in **toxicity**.
Explanation: **Explanation:** **Tularemia**, caused by the Gram-negative coccobacillus *Francisella tularensis*, is a highly infectious zoonotic disease. The aminoglycoside class of antibiotics is the cornerstone of therapy due to their bactericidal activity against this intracellular pathogen. **Why Streptomycin is the Correct Answer:** **Streptomycin** is historically and clinically recognized as the **drug of choice (DOC)** for Tularemia [1]. It is highly effective in reducing mortality and preventing relapses. While Gentamicin is a common alternative, Streptomycin remains the gold standard in medical literature and competitive exams for treating all clinical forms of Tularemia (ulceroglandular, pneumonic, etc.) [1]. **Analysis of Incorrect Options:** * **Kanamycin:** While an aminoglycoside, it is primarily used as a second-line drug for multi-drug resistant tuberculosis (MDR-TB) and is not the standard treatment for Tularemia. * **Neomycin:** This aminoglycoside is highly nephrotoxic and ototoxic when given systemically. Therefore, its use is restricted to topical applications or oral administration for "gut sterilization" (e.g., hepatic encephalopathy); it is never used for systemic infections like Tularemia. * **Chloramphenicol:** This is a bacteriostatic drug. While it can be used for Tularemia, it is associated with a high rate of relapse and potential bone marrow toxicity. It is generally reserved for Tularemia cases complicated by meningitis. **High-Yield Clinical Pearls for NEET-PG:** * **Alternative DOC:** Gentamicin is often used in clinical practice when Streptomycin is unavailable. * **Mild cases:** Fluoroquinolones (Ciprofloxacin) or Doxycycline can be used, but they carry a higher risk of relapse compared to aminoglycosides. * **Vector:** Tularemia is often transmitted via tick bites, deer flies, or contact with infected rabbits (**"Rabbit Fever"**). * **Bioterrorism:** *F. tularensis* is classified as a Category A bioterrorism agent due to its low infectious dose and ease of aerosolization.
Explanation: ### Explanation **Correct Option: B. Ethambutol** Ethambutol is a first-line antitubercular drug that inhibits the enzyme **arabinosyl transferase**, thereby interfering with mycobacterial cell wall synthesis. The most characteristic and high-yield side effect of Ethambutol is **Retrobulbar Neuritis**. This typically manifests as: 1. **Decreased visual acuity.** 2. **Central scotoma.** 3. **Loss of red-green color discrimination** (often the earliest sign). This toxicity is **dose-dependent** (usually seen at doses >25 mg/kg) and is generally reversible upon discontinuation of the drug. --- ### Why the other options are incorrect: * **A. Capreomycin:** This is an injectable second-line drug (cyclic peptide). Its primary toxicities are **nephrotoxicity** and **ototoxicity** (similar to aminoglycosides), not visual disturbances. * **C. Ethionamide:** This drug is structurally related to Isoniazid. Its major side effects include severe **gastrointestinal irritation**, **hepatotoxicity**, and **hypothyroidism**. While it can rarely cause peripheral neuropathy, it is not classically associated with red-green blindness. * **D. Other second-line agents:** Drugs like Cycloserine (neuropsychiatric issues) or Kanamycin (ototoxicity) do not typically cause optic neuritis. --- ### NEET-PG Clinical Pearls: * **Monitoring:** Patients on Ethambutol should undergo baseline and monthly **Snellen’s chart** and **Ishihara chart** testing. * **Pediatric Caution:** Ethambutol is generally avoided in children young enough that visual acuity cannot be accurately monitored (typically <6 years), though guidelines vary. * **Renal Adjustment:** Since Ethambutol is primarily excreted by the kidneys, the dose must be adjusted in renal failure to prevent accumulation and subsequent ocular toxicity. * **Mnemonic:** **E**thambutol for **E**ye (Optic neuritis).
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free